on INNATE PHARMA (EPA:IPH)
Innate Pharma participates in the Stifel 2025 Virtual Targeted Oncology Forum
On April 3, 2025, Innate Pharma SA announced its participation in the Stifel 2025 Virtual Targeted Oncology Forum. This event will take place from April 8 to 9, 2025. Members of the Innate leadership team will present and lead sessions at the forum. A fireside chat is scheduled for April 9, from 12:30 to 12:55 ET.
The presentation will be streamed live on the company's website in the "Events" section for investors. It will remain available for replay after the event.
Innate Pharma is listed on Euronext Paris and Nasdaq. It develops cancer immunotherapies using platforms such as ANKET®.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news